期刊文献+

乳腺癌新辅助化疗前后血清免疫指标CA15-3、CA125和CEA水平的变化 被引量:12

下载PDF
导出
摘要 目的:探讨乳腺癌患者新辅助化疗前后血清CA15-3、CA125和CEA水平的变化。方法:应用化学发光免疫分析法(CLIA)检测60例乳腺癌(Ⅰ期30例,II-IV期各10例)患者新辅助化疗前后血清CA15-3、CA125和CEA表达水平,并与60例非肿瘤患者作比较。结果:乳腺癌患者化疗前血清CA15-3、CA125和CEA含量显著高于非肿瘤患者组(P<0.01);三者联合检测较单一检测阳性率明显增高。Ⅰ+Ⅱ期患者行新辅助化疗3个疗程后CA15-3、CA125和CEA水平显著下降(P<0.05),与非肿瘤患者组比较无统计学差异;Ⅲ+Ⅳ期患者行新辅助化疗3个疗程后CA15-3、CA125和CEA水平明显下降(P<0.05),但仍高于非肿瘤患者组(P<0.05).结论:血清免疫指标CA15-3、CA125、CEA变化对临床诊断和预后观察具有重要的临床价值。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第11期1032-1033,1037,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30600597)
  • 相关文献

参考文献8

  • 1Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004 [J]. Ann Oncol, 2005, 16(3) : 481 -488.
  • 2Daidone MG, Silvestrini R. Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer [J].J Natl Cancer Inst Monogr, 2001, (30) : 27 -35.
  • 3Jeruss JS, Mittendorf EA, Tucker SL, et al. Staging of breast cancer in the neoadjuvant setting[J]. Cancer Res, 2008, 68(16) : 6477 - 6481.
  • 4Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value[J]. Clin Chem, 2006, 52(3) : 345 -351.
  • 5Brooks M. Breast cancer screening and biomarkers[J]. Methods Mol Biol, 2009, (13)472:307-321.
  • 6常鹏,陈江浩,于芳,王岭.树突状细胞应用于肿瘤免疫治疗的新进展[J].细胞与分子免疫学杂志,2008,24(10):1032-1033. 被引量:4
  • 7李小平,陈斌鸿,陈社安.血清CA153、CA125、CA199与CEA检测在乳腺癌诊断中的应用[J].广西医学,2004,26(7):975-977. 被引量:15
  • 8Arslan N, Serdar M, Deveci S, et al. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis [ J ]. Ann Nucl Med, 2000, 14(5) : 395 -399.

二级参考文献16

  • 1陈芳雪(综述),叶枫(审校),谢幸(审校).树突状细胞功能缺陷与肿瘤免疫逃逸[J].国际肿瘤学杂志,2007,34(9):641-643. 被引量:4
  • 2Cox K, North M, Burke M, et al. Plasmacytoid Dendritic Cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes[J]. J Leukoce Biol, 2005, 78(5) :1142 - 1152.
  • 3Villadangos JA, Heath WR. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells : Limitations of the Langerhans cells paradigm[ J ]. Semin Immunol, 2005, 17 (4) : 262 - 272.
  • 4Buettner M, Meinken C, Bastian M, et al. Inverse correlation of maturity and antibacterial activity in human dendritic celts[J]. J Immunol, 2005, 174(7) : 4203 - 4209.
  • 5Hansson M, Lundgren A, Elgbran K, et al. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3β) after exposure to Helicobacter pylori[ J]. Microbes Infect, 2006, 8(3) : 841 -850.
  • 6Ritter U, Wiede F, Mielenz D, et al. Analysis of the CCR7 expression on routine bone marrow derived and spleen dendritic cells[J]. J Leukoc Biol, 2004, 76(2) : 472 -476.
  • 7Jiang A, Bloom O, Ono S, et al. Disruption of E-cadherin-mediated adhesion induees a functionally distinct pathway of dendritic cell maturation[J]. Immunity, 2007, 27(4) : 610 -624.
  • 8He Y, Zhang J, Donahue C, et al. Skin-derived dendritic cells Induce potent CD8^+ T cell immunity in recombinant lentivector-mediated genetic immunization [ J ]. Immunity, 2006, 24 (5) : 643 - 656.
  • 9Botella-Estrada R, Dasi F, Ramos D, et al. Cytokine expression and dendritic cell density in melanoma sentinel nodes [ J ]. Melanoma Res, 2005, 15(2) : 99 - 106.
  • 10Angeli V, Ginhoux F, Llodra J, et al, B cell-driven lymphangiogenesis in inflamed lymph nodes enhanced dendritic cell mobilization [J]. Immunity, 2006, 24(2) : 203 -215.

共引文献17

同被引文献68

引证文献12

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部